198 related articles for article (PubMed ID: 24935722)
1. A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.
Bae J; Prabhala R; Voskertchian A; Brown A; Maguire C; Richardson P; Dranoff G; Anderson KC; Munshi NC
Leukemia; 2015 Jan; 29(1):218-29. PubMed ID: 24935722
[TBL] [Abstract][Full Text] [Related]
2. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.
Bae J; Carrasco R; Lee AH; Prabhala R; Tai YT; Anderson KC; Munshi NC
Leukemia; 2011 Oct; 25(10):1610-9. PubMed ID: 21660045
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
Bae J; Hideshima T; Zhang GL; Zhou J; Keskin DB; Munshi NC; Anderson KC
Leukemia; 2018 Mar; 32(3):752-764. PubMed ID: 29089645
[TBL] [Abstract][Full Text] [Related]
5. Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells.
Bae J; Samur M; Munshi A; Hideshima T; Keskin D; Kimmelman A; Lee AH; Dranoff G; Anderson KC; Munshi NC
Oncoimmunology; 2014; 3(12):e970914. PubMed ID: 25941601
[TBL] [Abstract][Full Text] [Related]
6. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
Bae J; Tai YT; Anderson KC; Munshi NC
Br J Haematol; 2011 Nov; 155(3):349-61. PubMed ID: 21902685
[TBL] [Abstract][Full Text] [Related]
7. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.
Bae J; Song W; Smith R; Daley J; Tai YT; Anderson KC; Munshi NC
Br J Haematol; 2012 Jun; 157(6):687-701. PubMed ID: 22533610
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Bae J; Hideshima T; Tai YT; Song Y; Richardson P; Raje N; Munshi NC; Anderson KC
Leukemia; 2018 Sep; 32(9):1932-1947. PubMed ID: 29487385
[TBL] [Abstract][Full Text] [Related]
9. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3
Bae J; Keskin DB; Cowens K; Lee AH; Dranoff G; Munshi NC; Anderson KC
J Leuk (Los Angel); 2015 Jun; 3(2):. PubMed ID: 27668268
[TBL] [Abstract][Full Text] [Related]
11. Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.
Bae J; Accardi F; Hideshima T; Tai YT; Prabhala R; Shambley A; Wen K; Rowell S; Richardson PG; Munshi NC; Anderson KC
Leukemia; 2022 Jan; 36(1):138-154. PubMed ID: 34290359
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8
Bae J; Samur M; Richardson P; Munshi NC; Anderson KC
Leukemia; 2019 Sep; 33(9):2208-2226. PubMed ID: 30872779
[TBL] [Abstract][Full Text] [Related]
13. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
Bae J; Martinson JA; Klingemann HG
Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
[TBL] [Abstract][Full Text] [Related]
14. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
[TBL] [Abstract][Full Text] [Related]
15. Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.
Jalili A; Ozaki S; Hara T; Shibata H; Hashimoto T; Abe M; Nishioka Y; Matsumoto T
Blood; 2005 Nov; 106(10):3538-45. PubMed ID: 16037388
[TBL] [Abstract][Full Text] [Related]
16. BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8
Bae J; Parayath N; Ma W; Amiji M; Munshi N; Anderson KC
Leukemia; 2020 Jan; 34(1):210-223. PubMed ID: 31427721
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma.
Xie X; Chen Y; Hu Y; He Y; Zhang H; Li Y
Mol Cancer Ther; 2019 Dec; 18(12):2258-2269. PubMed ID: 31413179
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
Ohno S; Moriya O; Yoshimoto T; Hayashi H; Akatsuka T; Matsui M
Viral Immunol; 2006; 19(3):458-67. PubMed ID: 16987064
[TBL] [Abstract][Full Text] [Related]
19. Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes.
Ge HL; Wang Y; Wang SJ; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2006 Feb; 38(2):110-8. PubMed ID: 16474902
[TBL] [Abstract][Full Text] [Related]
20.
Khalaf WS; Garg M; Mohamed YS; Stover CM; Browning MJ
Front Immunol; 2019; 10():1792. PubMed ID: 31428094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
